1. Bryostatin-5 stimulates normal human hematopoiesis and inhibits proliferation of HL60 leukemic cells.
- Author
-
van der Hem KG, Dräger AM, Odding JH, Langenhuijsen MM, and Huijgens PC
- Subjects
- Bone Marrow drug effects, Bone Marrow Cells, Bryostatins, Cell Division drug effects, Cell Survival drug effects, Humans, Leukemia, Promyelocytic, Acute pathology, Macrolides, Stimulation, Chemical, Tumor Cells, Cultured, Antineoplastic Agents pharmacology, Hematopoiesis drug effects, Lactones pharmacology, Leukemia, Promyelocytic, Acute drug therapy
- Abstract
In this study we explored the effects of bryostatin-5 on the clonogenic response of normal bone marrow mononuclear (BM) cells and HL60 myeloid leukemia cells. Leukemic HL60 colony formation was strongly inhibited by bryostatin-5 depending on dose and schedule. An inhibitory effect on HL60 colony formation was readily demonstrated after 1 h of exposure, reaching a maximal inhibitory effect at 96 h. Normal BM cells differed in their clonogenic response: short-term exposure to bryostatin-5 resulted in increased clonogenicity while longstanding exposure to bryostatin-5 permitted the survival of a substantial fraction of committed progenitors. This differential modulation of normal and leukemic myeloid clonogenicity by bryostatin-5 suggests a possible role for bryostatin-5 in the treatment of acute myeloid leukemia.
- Published
- 1995
- Full Text
- View/download PDF